Search Results

There are 13331 results for: content related to: Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer

  1. You have free access to this content
    Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib

    International Journal of Cancer

    Volume 137, Issue 6, 15 September 2015, Pages: 1446–1456, Qiaoli Zhao, Nadine Kretschmer, Rudolf Bauer and Thomas Efferth

    Version of Record online : 6 MAR 2015, DOI: 10.1002/ijc.29483

  2. You have full text access to this Open Access content
    JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation

    Cancer Science

    Volume 103, Issue 10, October 2012, Pages: 1795–1802, Daijiro Harada, Nagio Takigawa, Nobuaki Ochi, Takashi Ninomiya, Masayuki Yasugi, Toshio Kubo, Hiromasa Takeda, Eiki Ichihara, Kadoaki Ohashi, Saburo Takata, Mitsune Tanimoto and Katsuyuki Kiura

    Version of Record online : 23 JUL 2012, DOI: 10.1111/j.1349-7006.2012.02363.x

  3. You have free access to this content
    Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer


    Volume 121, Issue 18, September 15, 2015, Pages: 3298–3306, Karen L. Reckamp, Marianna Koczywas, Mihaela C. Cristea, Jonathan E. Dowell, He-Jing Wang, Brian K. Gardner, Ginger L. Milne, Robert A. Figlin, Michael C. Fishbein, Robert M. Elashoff and Steven M. Dubinett

    Version of Record online : 29 MAY 2015, DOI: 10.1002/cncr.29480

  4. You have full text access to this Open Access content
    Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib

    Cancer Science

    Volume 100, Issue 9, September 2009, Pages: 1701–1707, Kohji Noguchi, Haruka Kawahara, Airi Kaji, Kazuhiro Katayama, Junko Mitsuhashi and Yoshikazu Sugimoto

    Version of Record online : 12 MAY 2009, DOI: 10.1111/j.1349-7006.2009.01213.x

  5. You have free access to this content
    Synergistic effect of targeting the epidermal growth factor receptor and hyaluronan synthesis in oesophageal squamous cell carcinoma cells

    British Journal of Pharmacology

    Volume 172, Issue 18, September 2015, Pages: 4560–4574, I Kretschmer, T Freudenberger, S Twarock and J W Fischer

    Version of Record online : 30 JUL 2015, DOI: 10.1111/bph.13240

  6. Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma

    Head & Neck

    Volume 35, Issue 9, September 2013, Pages: 1323–1330, Christina I. Tsien, Mukesh K. Nyati, Aarif Ahsan, Susmita G. Ramanand, Douglas B. Chepeha, Francis P. Worden, Joseph I. Helman, Nisha D'Silva, Carol R. Bradford, Gregory T. Wolf, Theodore S. Lawrence and Avraham Eisbruch

    Version of Record online : 21 AUG 2012, DOI: 10.1002/hed.23128

  7. Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinoma

    Head & Neck

    Volume 35, Issue 6, June 2013, Pages: 809–818, Fabienne Thomas, Paul Delmar, Sébastien Vergez, Philippe Rochaix, Isabelle Hennebelle, Patricia McLoughlin, Adil Benlyazid, Jérôme Sarini and Jean–Pierre Delord

    Version of Record online : 13 JUL 2012, DOI: 10.1002/hed.23036

  8. Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 2, April 2015, Pages: 232–239, Y. Emoto-Yamamoto, S. Iida, T. Kawanishi and M. Fukuoka

    Version of Record online : 17 NOV 2014, DOI: 10.1111/jcpt.12232

  9. You have full text access to this Open Access content
    Salvage treatment with erlotinib after gefitinib failure in advanced non-small-cell lung cancer patients with poor performance status: A matched-pair case–control study

    Thoracic Cancer

    Volume 3, Issue 1, February 2012, Pages: 27–33, Daxian Luo, Meijuan Huang, Xinxing Zhang, Min Yu, Bingwen Zou, Yanying Li, Jianlin Long, Jin Wang, Feng Peng, Yong Xu, Lu Li, Li Ren, Mei Hou and You Lu

    Version of Record online : 5 FEB 2012, DOI: 10.1111/j.1759-7714.2011.00087.x

  10. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics


    Volume 15, Issue 2-3, January 2015, Pages: 340–355, Xu Zhang, Natalya Belkina, Harrys Kishore Charles Jacob, Tapan Maity, Romi Biswas, Abhilash Venugopalan, Patrick G. Shaw, Min-Sik Kim, Raghothama Chaerkady, Akhilesh Pandey and Udayan Guha

    Version of Record online : 15 JAN 2015, DOI: 10.1002/pmic.201400315

  11. Evaluation of the Absolute Oral Bioavailability and Bioequivalence of Erlotinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in a Randomized, Crossover Study in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 3, March 2006, Pages: 282–290, Dr Paul Frohna, Dr Jianfeng Lu, Dr Steve Eppler, Dr Marta Hamilton, Ms Julie Wolf, Dr Ashok Rakhit, Dr Jie Ling, Dr Saraswati R. Kenkare-Mitra and Dr Bert L. Lum

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270005284193


    Clinical and Experimental Pharmacology and Physiology

    Volume 36, Issue 5-6, May/June 2009, Pages: 487–494, Xia Qian, Jing Li, Jianhua Ding, Zhiyuan Wang, Wenjing Zhang and Gang Hu

    Version of Record online : 8 OCT 2008, DOI: 10.1111/j.1440-1681.2008.05091.x

  13. You have free access to this content
    Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma


    Volume 59, Issue 4, April 2014, Pages: 1577–1590, Bryan C. Fuchs, Yujin Hoshida, Tsutomu Fujii, Lan Wei, Suguru Yamada, Gregory Y. Lauwers, Christopher M. McGinn, Danielle K. DePeralta, Xintong Chen, Toshihiko Kuroda, Michael Lanuti, Anthony D. Schmitt, Supriya Gupta, Andrew Crenshaw, Robert Onofrio, Bradley Taylor, Wendy Winckler, Nabeel Bardeesy, Peter Caravan, Todd R. Golub and Kenneth K. Tanabe

    Version of Record online : 28 FEB 2014, DOI: 10.1002/hep.26898

  14. Coadministration of Erlotinib and Curcumin Augmentatively Reduces Cell Viability in Lung Cancer Cells

    Phytotherapy Research

    Volume 28, Issue 5, May 2014, Pages: 728–735, Yoshikane Yamauchi, Yotaro Izumi, Jun Yamamoto and Hiroaki Nomori

    Version of Record online : 13 AUG 2013, DOI: 10.1002/ptr.5056

  15. You have full text access to this Open Access content
    Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non-small-cell lung cancer

    Cancer Science

    Volume 104, Issue 10, October 2013, Pages: 1346–1352, Naomi Ono, Toshikazu Yamazaki, Toshiyuki Tsukaguchi, Toshihiko Fujii, Kiyoaki Sakata, Atsushi Suda, Takuo Tsukuda, Toshiyuki Mio, Nobuya Ishii, Osamu Kondoh and Yuko Aoki

    Version of Record online : 20 AUG 2013, DOI: 10.1111/cas.12237

  16. You have full text access to this Open Access content
    Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 1-2, January-February 2010, Pages: 51–69, Luis Paz-Ares, Denis Soulières, Ivan Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell and Barbara Klughammer

    Version of Record online : 8 DEC 2009, DOI: 10.1111/j.1582-4934.2009.00991.x

  17. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

    Intervention Review

    The Cochrane Library

    Janette Greenhalgh, Kerry Dwan, Angela Boland, Victoria Bates, Fabio Vecchio, Yenal Dundar, Pooja Jain and John A Green

    Published Online : 25 MAY 2016, DOI: 10.1002/14651858.CD010383.pub2

  18. You have full text access to this OnlineOpen article
    Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung cancer during treatment with erlotinib


    Volume 120, Issue 24, December 15, 2014, Pages: 3896–3901, Boe S. Sorensen, Lin Wu, Wen Wei, Julie Tsai, Britta Weber, Ebba Nexo and Peter Meldgaard

    Version of Record online : 7 AUG 2014, DOI: 10.1002/cncr.28964

  19. You have free access to this content
    Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models

    International Journal of Cancer

    Volume 130, Issue 10, 15 May 2012, Pages: 2445–2454, Mi Young Cha, Kwang-Ok Lee, Mira Kim, Ji Yeon Song, Kyu Hang Lee, Jongmin Park, Yun Jung Chae, Young Hoon Kim, Kwee Hyun Suh, Gwan Sun Lee, Seung Bum Park and Maeng Sup Kim

    Version of Record online : 24 AUG 2011, DOI: 10.1002/ijc.26276

  20. Chemical and microbial stability of high moisture dried apricots during storage

    Journal of the Science of Food and Agriculture

    Volume 88, Issue 5, 15 April 2008, Pages: 858–869, Fatma Saǧırlı, Şeref Taǧı, Mehmet Özkan and Oktay Yemiş

    Version of Record online : 17 JAN 2008, DOI: 10.1002/jsfa.3162